2023-2029 Global Vinblastine Drug Industry Research & Trends Analysis Report

Publication Month: Mar 2023 | No. of Pages: 165 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Vinblastine Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Vinblastine Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Vinblastine Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Vinblastine segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Bladder Cancer has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Vinblastine Drug include AstraZeneca, Johnson & Johnson, Mylan NV, Teva Pharmaceutical Industries Ltd, Fresenius Kabi AG, Pfizer Inc, GlaxoSmithKline plc, Novartis AG and Sanofi, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Vinblastine is a chemotherapy drug that is often used with other drugs to treat many types of cancer. This includes Hodgkin's lymphoma, non-small cell lung cancer, bladder cancer, brain cancer, melanoma, and testicular cancer. It is given by injection into a vein.
This report aims to provide a comprehensive study of the global market for Vinblastine Drug. Report Highlights:
(1) Global Vinblastine Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Vinblastine Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Vinblastine Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Vinblastine Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Vinblastine Drug segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Vinblastine Drug, capacity, production and trends.
(7) Vinblastine Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Vinblastine
Vincristine
Vinorelbine
Vinflunine
Vindesine
Market segment by application, can be divided into
Bladder Cancer
Breast Cancer
Acute Leukemia
Lymphoma
Melanoma
Non-Small Cell Lung Cancer
Other
Market segment by players, this report covers
AstraZeneca
Johnson & Johnson
Mylan NV
Teva Pharmaceutical Industries Ltd
Fresenius Kabi AG
Pfizer Inc
GlaxoSmithKline plc
Novartis AG
Sanofi
Merck & Co., Inc
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Abbott
Sagent Pharmaceuticals, Inc
Hikma Pharmaceuticals PLC
Dr. Reddy's Laboratories Ltd
Eli Lilly
Aurobindo Pharma
Amneal Pharmaceuticals LLC
Pierre Fabre

1 Market Overview
1.1 Vinblastine Drug Definition
1.2 Global Vinblastine Drug Market Size and Forecast
1.2.1 By Revenue, Global Vinblastine Drug Market Size, 2018-2029
1.2.2 By Sales Volume, Global Vinblastine Drug Market Size, 2018-2029
1.2.3 Global Vinblastine Drug Price Trend, 2018-2029
1.3 China Vinblastine Drug Market Size and Forecast
1.3.1 By Revenue, China Vinblastine Drug Market Size, 2018-2029
1.3.2 By Sales Volume, China Vinblastine Drug Market Size, 2018-2029
1.3.3 China Vinblastine Drug Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Vinblastine Drug Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Vinblastine Drug Share in Global Market, 2018-2029
1.4.3 Vinblastine Drug Market Size: China VS Global, 2018-2029
1.5 Vinblastine Drug Market Dynamics
1.5.1 Vinblastine Drug Market Drivers
1.5.2 Vinblastine Drug Market Restraints
1.5.3 Vinblastine Drug Industry Trends
1.5.4 Vinblastine Drug Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Vinblastine Drug Revenue by Company, 2018-2023
2.2 Global Vinblastine Drug Sales Volume by Company, 2018-2023
2.3 Global Vinblastine Drug Price by Company, 2018-2023
2.4 Global Vinblastine Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Vinblastine Drug Concentration Ratio
2.6 Global Vinblastine Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Vinblastine Drug Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Vinblastine Drug Revenue by Company, 2018-2023
3.2 China Vinblastine Drug Sales Volume by Company, 2018-2023
3.3 China Vinblastine Drug Vinblastine Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Vinblastine Drug Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Vinblastine Drug Domestic VS Export
3.6 China Market, Vinblastine Drug Import & Export
3.6.1 China Market, Vinblastine Drug Import & Export, 2018-2029
3.6.2 China Vinblastine Drug Import & Export Trends
3.6.3 Main Sources of China Vinblastine Drug Import
3.6.4 Export Destination of China Vinblastine Drug
4 Vinblastine Drug Production by Region
4.1 Global Vinblastine Drug Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Vinblastine Drug Manufacturers
4.3 Global Major Manufacturers, Vinblastine Drug Capacity Expansion and Future Plans
4.4 Global Vinblastine Drug Capacity by Region
4.5 Global Vinblastine Drug Production by Region
4.5.1 Global Vinblastine Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Vinblastine Drug Production by Region, 2018-2023
4.5.3 Global Vinblastine Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Vinblastine Drug Industry Chain
5.2 Vinblastine Drug Upstream Analysis
5.2.1 Vinblastine Drug Core Raw Materials
5.2.2 Main Manufacturers of Vinblastine Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Vinblastine Drug Production Mode
5.6 Vinblastine Drug Procurement Model
5.7 Vinblastine Drug Industry Sales Model and Sales Channels
5.7.1 Vinblastine Drug Sales Model
5.7.2 Vinblastine Drug Typical Distributors
6 Sights by Type
6.1 Vinblastine Drug Classification
6.1.1 Vinblastine
6.1.2 Vincristine
6.1.3 Vinorelbine
6.1.4 Vinflunine
6.1.5 Vindesine
6.2 By Type, Global Vinblastine Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Vinblastine Drug Revenue, 2018-2029
6.4 By Type, Global Vinblastine Drug Sales Volume, 2018-2029
6.5 By Type, Global Vinblastine Drug Price, 2018-2029
7 Sights by Application
7.1 Vinblastine Drug Segment by Application
7.1.1 Bladder Cancer
7.1.2 Breast Cancer
7.1.3 Acute Leukemia
7.1.4 Lymphoma
7.1.5 Melanoma
7.1.6 Non-Small Cell Lung Cancer
7.1.7 Other
7.2 By Application, Global Vinblastine Drug Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Vinblastine Drug Revenue, 2018-2029
7.4 By Application, Global Vinblastine Drug Sales Volume, 2018-2029
7.5 By Application, Global Vinblastine Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Vinblastine Drug Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Vinblastine Drug Revenue, 2018-2029
8.3 By Region, Global Vinblastine Drug Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Vinblastine Drug Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Vinblastine Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Vinblastine Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Vinblastine Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Vinblastine Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Vinblastine Drug Market Size Market Share
8.7 South America
8.7.1 South America Vinblastine Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Vinblastine Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Vinblastine Drug Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Vinblastine Drug Revenue, 2018-2029
9.3 By Country, Global Vinblastine Drug Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Vinblastine Drug Market Size, 2018-2029
9.4.2 By Company, U.S. Vinblastine Drug Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Vinblastine Drug Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Vinblastine Drug Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Vinblastine Drug Market Size, 2018-2029
9.5.2 By Company, Europe Vinblastine Drug Sales Volume Market Share, 2022
9.5.3 By Type, Europe Vinblastine Drug Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Vinblastine Drug Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Vinblastine Drug Market Size, 2018-2029
9.6.2 By Company, China Vinblastine Drug Sales Volume Market Share, 2022
9.6.3 By Type, China Vinblastine Drug Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Vinblastine Drug Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Vinblastine Drug Market Size, 2018-2029
9.7.2 By Company, Japan Vinblastine Drug Sales Volume Market Share, 2022
9.7.3 By Type, Japan Vinblastine Drug Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Vinblastine Drug Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Vinblastine Drug Market Size, 2018-2029
9.8.2 By Company, South Korea Vinblastine Drug Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Vinblastine Drug Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Vinblastine Drug Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Vinblastine Drug Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Vinblastine Drug Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Vinblastine Drug Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Vinblastine Drug Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Vinblastine Drug Market Size, 2018-2029
9.10.2 By Company, India Vinblastine Drug Sales Volume Market Share, 2022
9.10.3 By Type, India Vinblastine Drug Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Vinblastine Drug Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Vinblastine Drug Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Vinblastine Drug Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Vinblastine Drug Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Vinblastine Drug Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.1.2 AstraZeneca Vinblastine Drug Models, Specifications and Application
10.1.3 AstraZeneca Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 AstraZeneca Company Profile and Main Business
10.1.5 AstraZeneca Recent Developments
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
10.2.2 Johnson & Johnson Vinblastine Drug Models, Specifications and Application
10.2.3 Johnson & Johnson Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Johnson & Johnson Company Profile and Main Business
10.2.5 Johnson & Johnson Recent Developments
10.3 Mylan NV
10.3.1 Mylan NV Company Information, Head Office, Market Area and Industry Position
10.3.2 Mylan NV Vinblastine Drug Models, Specifications and Application
10.3.3 Mylan NV Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Mylan NV Company Profile and Main Business
10.3.5 Mylan NV Recent Developments
10.4 Teva Pharmaceutical Industries Ltd
10.4.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.4.2 Teva Pharmaceutical Industries Ltd Vinblastine Drug Models, Specifications and Application
10.4.3 Teva Pharmaceutical Industries Ltd Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.4.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.5 Fresenius Kabi AG
10.5.1 Fresenius Kabi AG Company Information, Head Office, Market Area and Industry Position
10.5.2 Fresenius Kabi AG Vinblastine Drug Models, Specifications and Application
10.5.3 Fresenius Kabi AG Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Fresenius Kabi AG Company Profile and Main Business
10.5.5 Fresenius Kabi AG Recent Developments
10.6 Pfizer Inc
10.6.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.6.2 Pfizer Inc Vinblastine Drug Models, Specifications and Application
10.6.3 Pfizer Inc Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Pfizer Inc Company Profile and Main Business
10.6.5 Pfizer Inc Recent Developments
10.7 GlaxoSmithKline plc
10.7.1 GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position
10.7.2 GlaxoSmithKline plc Vinblastine Drug Models, Specifications and Application
10.7.3 GlaxoSmithKline plc Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 GlaxoSmithKline plc Company Profile and Main Business
10.7.5 GlaxoSmithKline plc Recent Developments
10.8 Novartis AG
10.8.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.8.2 Novartis AG Vinblastine Drug Models, Specifications and Application
10.8.3 Novartis AG Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Novartis AG Company Profile and Main Business
10.8.5 Novartis AG Recent Developments
10.9 Sanofi
10.9.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.9.2 Sanofi Vinblastine Drug Models, Specifications and Application
10.9.3 Sanofi Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Sanofi Company Profile and Main Business
10.9.5 Sanofi Recent Developments
10.10 Merck & Co., Inc
10.10.1 Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
10.10.2 Merck & Co., Inc Vinblastine Drug Models, Specifications and Application
10.10.3 Merck & Co., Inc Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Merck & Co., Inc Company Profile and Main Business
10.10.5 Merck & Co., Inc Recent Developments
10.11 F. Hoffmann-La Roche Ltd
10.11.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.11.2 F. Hoffmann-La Roche Ltd Vinblastine Drug Models, Specifications and Application
10.11.3 F. Hoffmann-La Roche Ltd Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.11.5 F. Hoffmann-La Roche Ltd Recent Developments
10.12 Bristol-Myers Squibb Company
10.12.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.12.2 Bristol-Myers Squibb Company Vinblastine Drug Models, Specifications and Application
10.12.3 Bristol-Myers Squibb Company Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.12.5 Bristol-Myers Squibb Company Recent Developments
10.13 Abbott
10.13.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.13.2 Abbott Vinblastine Drug Models, Specifications and Application
10.13.3 Abbott Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Abbott Company Profile and Main Business
10.13.5 Abbott Recent Developments
10.14 Sagent Pharmaceuticals, Inc
10.14.1 Sagent Pharmaceuticals, Inc Company Information, Head Office, Market Area and Industry Position
10.14.2 Sagent Pharmaceuticals, Inc Vinblastine Drug Models, Specifications and Application
10.14.3 Sagent Pharmaceuticals, Inc Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Sagent Pharmaceuticals, Inc Company Profile and Main Business
10.14.5 Sagent Pharmaceuticals, Inc Recent Developments
10.15 Hikma Pharmaceuticals PLC
10.15.1 Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
10.15.2 Hikma Pharmaceuticals PLC Vinblastine Drug Models, Specifications and Application
10.15.3 Hikma Pharmaceuticals PLC Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Hikma Pharmaceuticals PLC Company Profile and Main Business
10.15.5 Hikma Pharmaceuticals PLC Recent Developments
10.16 Dr. Reddy's Laboratories Ltd
10.16.1 Dr. Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
10.16.2 Dr. Reddy's Laboratories Ltd Vinblastine Drug Models, Specifications and Application
10.16.3 Dr. Reddy's Laboratories Ltd Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Dr. Reddy's Laboratories Ltd Company Profile and Main Business
10.16.5 Dr. Reddy's Laboratories Ltd Recent Developments
10.17 Eli Lilly
10.17.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
10.17.2 Eli Lilly Vinblastine Drug Models, Specifications and Application
10.17.3 Eli Lilly Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Eli Lilly Company Profile and Main Business
10.17.5 Eli Lilly Recent Developments
10.18 Aurobindo Pharma
10.18.1 Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
10.18.2 Aurobindo Pharma Vinblastine Drug Models, Specifications and Application
10.18.3 Aurobindo Pharma Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Aurobindo Pharma Company Profile and Main Business
10.18.5 Aurobindo Pharma Recent Developments
10.19 Amneal Pharmaceuticals LLC
10.19.1 Amneal Pharmaceuticals LLC Company Information, Head Office, Market Area and Industry Position
10.19.2 Amneal Pharmaceuticals LLC Vinblastine Drug Models, Specifications and Application
10.19.3 Amneal Pharmaceuticals LLC Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Amneal Pharmaceuticals LLC Company Profile and Main Business
10.19.5 Amneal Pharmaceuticals LLC Recent Developments
10.20 Pierre Fabre
10.20.1 Pierre Fabre Company Information, Head Office, Market Area and Industry Position
10.20.2 Pierre Fabre Vinblastine Drug Models, Specifications and Application
10.20.3 Pierre Fabre Vinblastine Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Pierre Fabre Company Profile and Main Business
10.20.5 Pierre Fabre Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

Tables and Figures

Table 1. Vinblastine Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Vinblastine Drug Market Restraints
Table 3. Vinblastine Drug Market Trends
Table 4. Vinblastine Drug Industry Policy
Table 5. Global Vinblastine Drug Revenue by Company, 2018-2023, US$ million
Table 6. Global Vinblastine Drug Revenue Market Share by Company, 2018-2023
Table 7. Global Vinblastine Drug Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Vinblastine Drug Sales Volume Market Share by Company, 2018-2023
Table 9. Global Vinblastine Drug Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Vinblastine Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Vinblastine Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Vinblastine Drug Manufacturers Product Type
Table 13. China Vinblastine Drug Revenue by Company, 2018-2023, US$ million
Table 14. China Vinblastine Drug Revenue Market Share by Company, 2018-2023
Table 15. China Vinblastine Drug Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Vinblastine Drug Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Vinblastine Drug Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Vinblastine Drug Import & Export Trends
Table 19. Main Sources of China Vinblastine Drug Import
Table 20. Export Destination of China Vinblastine Drug
Table 21. Global Headquarters and Manufacturing Base of Vinblastine Drug Manufacturers
Table 22. Global Major Manufacturers, Vinblastine Drug Capacity Expansion and Future Plans
Table 23. Global Vinblastine Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Vinblastine Drug Production by Region, 2018-2023, (K Units)
Table 25. Global Vinblastine Drug Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Vinblastine Drug Upstream (Raw Materials)
Table 27. Global Vinblastine Drug Typical Customers
Table 28. Vinblastine Drug Typical Distributors
Table 29. By Type, Global Vinblastine Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Vinblastine Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Vinblastine Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Vinblastine Drug Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Vinblastine Drug Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Vinblastine Drug Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Vinblastine Drug Revenue Market Share, 2018-2029
Table 37. By Country, Global Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Vinblastine Drug Sales Volume Market Share, 2018-2029
Table 39. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 40. AstraZeneca Vinblastine Drug Models, Specifications and Application
Table 41. AstraZeneca Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. AstraZeneca Company Profile and Main Business
Table 43. AstraZeneca Recent Developments
Table 44. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 45. Johnson & Johnson Vinblastine Drug Models, Specifications and Application
Table 46. Johnson & Johnson Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Johnson & Johnson Company Profile and Main Business
Table 48. Johnson & Johnson Recent Developments
Table 49. Mylan NV Company Information, Head Office, Market Area and Industry Position
Table 50. Mylan NV Vinblastine Drug Models, Specifications and Application
Table 51. Mylan NV Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Mylan NV Company Profile and Main Business
Table 53. Mylan NV Recent Developments
Table 54. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 55. Teva Pharmaceutical Industries Ltd Vinblastine Drug Models, Specifications and Application
Table 56. Teva Pharmaceutical Industries Ltd Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 58. Teva Pharmaceutical Industries Ltd Recent Developments
Table 59. Fresenius Kabi AG Company Information, Head Office, Market Area and Industry Position
Table 60. Fresenius Kabi AG Vinblastine Drug Models, Specifications and Application
Table 61. Fresenius Kabi AG Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Fresenius Kabi AG Company Profile and Main Business
Table 63. Fresenius Kabi AG Recent Developments
Table 64. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 65. Pfizer Inc Vinblastine Drug Models, Specifications and Application
Table 66. Pfizer Inc Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Pfizer Inc Company Profile and Main Business
Table 68. Pfizer Inc Recent Developments
Table 69. GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position
Table 70. GlaxoSmithKline plc Vinblastine Drug Models, Specifications and Application
Table 71. GlaxoSmithKline plc Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. GlaxoSmithKline plc Company Profile and Main Business
Table 73. GlaxoSmithKline plc Recent Developments
Table 74. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 75. Novartis AG Vinblastine Drug Models, Specifications and Application
Table 76. Novartis AG Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Novartis AG Company Profile and Main Business
Table 78. Novartis AG Recent Developments
Table 79. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 80. Sanofi Vinblastine Drug Models, Specifications and Application
Table 81. Sanofi Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Sanofi Company Profile and Main Business
Table 83. Sanofi Recent Developments
Table 84. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
Table 85. Merck & Co., Inc Vinblastine Drug Models, Specifications and Application
Table 86. Merck & Co., Inc Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Merck & Co., Inc Company Profile and Main Business
Table 88. Merck & Co., Inc Recent Developments
Table 89. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 90. F. Hoffmann-La Roche Ltd Vinblastine Drug Models, Specifications and Application
Table 91. F. Hoffmann-La Roche Ltd Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 93. F. Hoffmann-La Roche Ltd Recent Developments
Table 94. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
Table 95. Bristol-Myers Squibb Company Vinblastine Drug Models, Specifications and Application
Table 96. Bristol-Myers Squibb Company Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Bristol-Myers Squibb Company Company Profile and Main Business
Table 98. Bristol-Myers Squibb Company Recent Developments
Table 99. Abbott Company Information, Head Office, Market Area and Industry Position
Table 100. Abbott Vinblastine Drug Models, Specifications and Application
Table 101. Abbott Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Abbott Company Profile and Main Business
Table 103. Abbott Recent Developments
Table 104. Sagent Pharmaceuticals, Inc Company Information, Head Office, Market Area and Industry Position
Table 105. Sagent Pharmaceuticals, Inc Vinblastine Drug Models, Specifications and Application
Table 106. Sagent Pharmaceuticals, Inc Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Sagent Pharmaceuticals, Inc Company Profile and Main Business
Table 108. Sagent Pharmaceuticals, Inc Recent Developments
Table 109. Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
Table 110. Hikma Pharmaceuticals PLC Vinblastine Drug Models, Specifications and Application
Table 111. Hikma Pharmaceuticals PLC Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Hikma Pharmaceuticals PLC Company Profile and Main Business
Table 113. Hikma Pharmaceuticals PLC Recent Developments
Table 114. Dr. Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
Table 115. Dr. Reddy's Laboratories Ltd Vinblastine Drug Models, Specifications and Application
Table 116. Dr. Reddy's Laboratories Ltd Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Dr. Reddy's Laboratories Ltd Company Profile and Main Business
Table 118. Dr. Reddy's Laboratories Ltd Recent Developments
Table 119. Eli Lilly Company Information, Head Office, Market Area and Industry Position
Table 120. Eli Lilly Vinblastine Drug Models, Specifications and Application
Table 121. Eli Lilly Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Eli Lilly Company Profile and Main Business
Table 123. Eli Lilly Recent Developments
Table 124. Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
Table 125. Aurobindo Pharma Vinblastine Drug Models, Specifications and Application
Table 126. Aurobindo Pharma Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Aurobindo Pharma Company Profile and Main Business
Table 128. Aurobindo Pharma Recent Developments
Table 129. Amneal Pharmaceuticals LLC Company Information, Head Office, Market Area and Industry Position
Table 130. Amneal Pharmaceuticals LLC Vinblastine Drug Models, Specifications and Application
Table 131. Amneal Pharmaceuticals LLC Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Amneal Pharmaceuticals LLC Company Profile and Main Business
Table 133. Amneal Pharmaceuticals LLC Recent Developments
Table 134. Pierre Fabre Company Information, Head Office, Market Area and Industry Position
Table 135. Pierre Fabre Vinblastine Drug Models, Specifications and Application
Table 136. Pierre Fabre Vinblastine Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 137. Pierre Fabre Company Profile and Main Business
Table 138. Pierre Fabre Recent Developments
List of Figure
Figure 1. Vinblastine Drug Picture
Figure 2. By Revenue, Global Vinblastine Drug Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Vinblastine Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Vinblastine Drug Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Vinblastine Drug Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Vinblastine Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Vinblastine Drug Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Vinblastine Drug Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Vinblastine Drug Share of Global Market, 2018-2029
Figure 10. Global Vinblastine Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Vinblastine Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Vinblastine Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Vinblastine Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Vinblastine Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Vinblastine Drug Domestic VS Export, 2022
Figure 16. Global Vinblastine Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Vinblastine Drug Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Vinblastine Drug Production Market Share & Forecast by Region, 2018-2029
Figure 19. Vinblastine Drug Industry Chain
Figure 20. Vinblastine Drug Procurement Model
Figure 21. Vinblastine Drug Sales Model
Figure 22. Vinblastine Drug Sales Channels, Direct Sales and Distribution
Figure 23. Vinblastine
Figure 24. Vincristine
Figure 25. Vinorelbine
Figure 26. Vinflunine
Figure 27. Vindesine
Figure 28. By Type, Global Vinblastine Drug Revenue, 2018-2029, US$ Million
Figure 29. By Type, Global Vinblastine Drug Revenue Market Share, 2018-2029
Figure 30. By Type, Global Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 31. By Type, Global Vinblastine Drug Sales Volume Market Share, 2018-2029
Figure 32. By Type, Global Vinblastine Drug Price, 2018-2029, (US$/Unit)
Figure 33. Bladder Cancer
Figure 34. Breast Cancer
Figure 35. Acute Leukemia
Figure 36. Lymphoma
Figure 37. Melanoma
Figure 38. Non-Small Cell Lung Cancer
Figure 39. Other
Figure 40. By Application, Global Vinblastine Drug Revenue, 2018-2029, US$ Million
Figure 41. By Application, Global Vinblastine Drug Revenue Market Share, 2018-2029
Figure 42. By Application, Global Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 43. By Application, Global Vinblastine Drug Sales Volume Market Share, 2018-2029
Figure 44. By Application, Global Vinblastine Drug Price, 2018-2029, (US$/Unit)
Figure 45. By Region, Global Vinblastine Drug Revenue Market Share, 2018-2029
Figure 46. By Region, Global Vinblastine Drug Sales Volume Market Share, 2018-2029
Figure 47. North America Vinblastine Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, North America Vinblastine Drug Revenue Market Share, 2022
Figure 49. Europe Vinblastine Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, Europe Vinblastine Drug Revenue Market Share, 2022
Figure 51. Asia Pacific Vinblastine Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. By Country/Region, Asia Pacific Vinblastine Drug Revenue Market Share, 2022
Figure 53. South America Vinblastine Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 54. By Country, South America Vinblastine Drug Revenue Market Share, 2022
Figure 55. Middle East & Africa Vinblastine Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 56. U.S. Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, U.S. Vinblastine Drug Market Share, 2022
Figure 58. By Type, U.S. Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, U.S. Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 60. Europe Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, Europe Vinblastine Drug Market Share, 2022
Figure 62. By Type, Europe Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, Europe Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 64. China Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, China Vinblastine Drug Market Share, 2022
Figure 66. By Type, China Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, China Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 68. Japan Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, Japan Vinblastine Drug Market Share, 2022
Figure 70. By Type, Japan Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, Japan Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 72. South Korea Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, South Korea Vinblastine Drug Market Share, 2022
Figure 74. By Type, South Korea Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, South Korea Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 76. Southeast Asia Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, Southeast Asia Vinblastine Drug Market Share, 2022
Figure 78. By Type, Southeast Asia Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, Southeast Asia Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 80. India Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 81. By Company, India Vinblastine Drug Market Share, 2022
Figure 82. By Type, India Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, India Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 84. Middle East & Asia Vinblastine Drug Sales Volume, 2018-2029, (K Units)
Figure 85. By Company, Middle East & Asia Vinblastine Drug Market Share, 2022
Figure 86. By Type, Middle East & Asia Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 87. By Application, Middle East & Asia Vinblastine Drug Sales Volume Market Share, 2022 VS 2029
Figure 88. Research Methodology
Figure 89. Breakdown of Primary Interviews
Figure 90. Bottom-up Approaches
Figure 91. Top-down Approaches



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets